Drug Profile
Research programme: long acting GIP analogues - Amylin
Alternative Names: AC 165072; AC 165081Latest Information Update: 10 Mar 2010
Price :
$50
*
At a glance
- Originator Amylin Pharmaceuticals
- Class Antihyperglycaemics; Hormones; Neuropeptides
- Mechanism of Action Gastric inhibitory polypeptide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus